DTHIB binds HSF1 directly and degrades HSF1 in the nucleus, thereby decreasing its nuclear activity and ultimately lowering its transcriptional activity in prostate cancer (Dong et al., 2020). This evidence concerns the gene HSF1 and prostate cancer.